Comparative safety and efficacy of molecular-targeted drugs, immune checkpoint inhibitors, hepatic arterial infusion chemotherapy and their combinations in advanced hepatocellular carcinoma: findings from advances in landmark trials

Yangxun Pan, Zhongguo Zhou, Dandan Hu et al.|Frontiers in Bioscience-Landmark|2021

Cited by 19